WO2004089305A3 - Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same - Google Patents

Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same Download PDF

Info

Publication number
WO2004089305A3
WO2004089305A3 PCT/US2004/009742 US2004009742W WO2004089305A3 WO 2004089305 A3 WO2004089305 A3 WO 2004089305A3 US 2004009742 W US2004009742 W US 2004009742W WO 2004089305 A3 WO2004089305 A3 WO 2004089305A3
Authority
WO
WIPO (PCT)
Prior art keywords
heparin
methods
soluble
presently
heparosan
Prior art date
Application number
PCT/US2004/009742
Other languages
French (fr)
Other versions
WO2004089305A2 (en
Inventor
Paul Deangelis
Original Assignee
Paul Deangelis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paul Deangelis filed Critical Paul Deangelis
Publication of WO2004089305A2 publication Critical patent/WO2004089305A2/en
Publication of WO2004089305A3 publication Critical patent/WO2004089305A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The presently claimed and disclosed invention relates, in general, to single action, dual action and soluble heparin synthases and, more particularly, to single action, dual action and soluble heparin synthases obtained from Pasteurella multocida. The presently claimed and disclosed invention also relates to heparosan, heparin and heparin-like molecules provided by recombinant techniques and methods of using such molecules. The presently claimed and disclosed invention also relates to methods, and molecules produced according to such methods, for using the presently claimed and disclosed heparosan and/or heparin synthase for polymer grafting and the production of non­naturally occurring chimeric polymers incorporating stretches of one or more acidic GAG molecules, such as heparin, chondroitin, hyaluronan, and/or heparosan.
PCT/US2004/009742 2003-03-31 2004-03-31 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same WO2004089305A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45893903P 2003-03-31 2003-03-31
US60/458,939 2003-03-31

Publications (2)

Publication Number Publication Date
WO2004089305A2 WO2004089305A2 (en) 2004-10-21
WO2004089305A3 true WO2004089305A3 (en) 2006-09-28

Family

ID=33159608

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/009742 WO2004089305A2 (en) 2003-03-31 2004-03-31 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same

Country Status (1)

Country Link
WO (1) WO2004089305A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111154819B (en) * 2020-01-15 2022-08-30 山东大学 Non-animal source low molecular weight heparin and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089742A2 (en) * 2001-05-08 2002-11-14 The Board Of Regents Of The University Of Oklahoma Heparin/heparosan synthase and methods of making and using same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002089742A2 (en) * 2001-05-08 2002-11-14 The Board Of Regents Of The University Of Oklahoma Heparin/heparosan synthase and methods of making and using same

Also Published As

Publication number Publication date
WO2004089305A2 (en) 2004-10-21

Similar Documents

Publication Publication Date Title
WO2002089742A3 (en) Heparin/heparosan synthase and methods of making and using same
WO2005112888A3 (en) Methods for making injectable polymer hydrogels
EP2404939A3 (en) Low molecular weight heparin composition and uses thereof
Wang et al. Chemical components and molecular mass of six polysaccharides isolated from the sclerotium of Poria cocos
WO2000027437A3 (en) Polymer grafting by polysaccharide synthases
Domard et al. Glucosamine oligomers: 1. Preparation and characterization
WO2005072371A3 (en) Branched polymeric sugars and nucleotides thereof
WO2007061664A3 (en) Copolymers produced from reacting a glycidyl ester and/or ether with a polyol and the use of the copolymers in coating compositions
WO2005121185A8 (en) Process for preparation of polysaccharide-grafted polymer particles
AU2002352666A1 (en) Process for the production of branched melt polycarbonate by late addition of fries-inducing catalyst
WO2006081583A3 (en) Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
TW200714667A (en) Fatigue resistant thermoplastic composition, method of making, and articles formed therefrom
WO2008152917A1 (en) Olefin/aromatic vinyl copolymer, process for production thereof, resin compositions containing the copolymer, and stretched products of the copolymer
EP1832662A3 (en) DNA encoding chondroitin synthase from Pasteurella multocida and methods of use
ATE443756T1 (en) CHONDROITIN SYNTHASE GENE AND METHOD FOR THE PRODUCTION AND USE THEREOF
Revuelta et al. Heparanized chitosans: Towards the third generation of chitinous biomaterials
WO2017020043A3 (en) Biosynthesis of polyketides
WO2004089305A3 (en) Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same
WO2010133288A3 (en) Polymers obtainable from oxetane based macromonomers, method for the production thereof, and the use thereof as additives in coating agents and plastics
WO2005121204A3 (en) Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor
WO2003029261A3 (en) Glycosaminoglycan polymers and methods of making and using same
BRPI0413512A (en) water-soluble cationic polymer composition
WO2010133289A3 (en) Terminally unsaturated, oxetane-based macromonomers, and method for the production thereof
AU8032800A (en) Derivatized reduced malto-oligosaccharides
KR20190022717A (en) Unsaturated derivatives of polysaccharides, their preparation methods and uses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase